Skip to content
DataLookout
Start free
Menu

NCT07229651

Metformin in Parkinson Disease

StatusRecruiting
PhasePhase 2/3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

change in The Unified Parkinson's Disease Rating Scale (UPDRS).
Timeframe: 6 months

Secondary (1)

Change in PDQ-39

Arms and interventions

Control groupActive comparator

Control group (Levo-dopa group, n =30) who will receive levodopa/carbidopa (125/12.5 mg) three times daily for 6 months

Metformin groupActive comparator

Patients will receive levodopa/carbidopa (125/12.5 mg) three times daily plus metformin 500 mg two times daily for 6 months

Drugs: Levodopa Carbidopa, Metformin

Sites

1 site in 1 country

  • Tanta UniversityTanta, Egypt